Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Adicionar filtros








Intervalo de ano
1.
São Paulo med. j ; 129(4): 271-275, 2011. ilus, tab
Artigo em Inglês | LILACS | ID: lil-601181

RESUMO

CONTEXT: Transperitoneal migration is a mechanism for oocyte retrieval that is generally demonstrated in certain cases of ectopic pregnancy. However, the association between these two conditions is debatable. The rare occasions on which intrauterine pregnancy following transperitoneal migration can be documented are an opportunity for studying this topic. CASE REPORT: We report the case of a female with a history of salpingectomy due to an ectopic pregnancy at 31 years of age. Two subsequent pregnancies were intrauterine. In both of them, ultrasound revealed that the corpus luteum was located in the ovary ipsilateral to the salpingectomy. CONCLUSION: To our knowledge, this is the first reported case of two intrauterine pregnancies following transperitoneal migration, carried to term, and resulting in the delivery of two healthy children. The clinical and physiological implications are discussed.


CONTEXTO: A migração transperitoneal é um mecanismo de captação do oócito demonstrado, em geral, em determinados casos de gravidez ectópica. No entanto, a associação entre ambas é discutível. As raras ocasiões em que uma gestação intrauterina após migração transperitoneal pode ser documentada são uma oportunidade para o estudo deste tópico. RELATO DE CASO: Relatamos o caso de uma mulher com salpingectomia aos 31 anos, por gravidez ectópica. Duas gestações subsequentes foram intrauterinas. Em ambas, ultrassonografia evidenciou presença do corpo lúteo em ovário do mesmo lado da salpingectomia. CONCLUSÃO: No nosso conhecimento, trata-se do primeiro caso relatado com duas gestações intrauterinas após migração transperitoneal, terminadas com o nascimento de duas crianças saudáveis. As implicações clínicas e fisiológicas são discutidas.


Assuntos
Adulto , Feminino , Humanos , Gravidez , Recuperação de Oócitos/métodos , Transporte do Óvulo , Cavidade Peritoneal , Resultado da Gravidez , Gravidez Ectópica , Gravidez Ectópica/diagnóstico , Recidiva , Salpingectomia
2.
Biol. Res ; 40(2): 213-222, 2007. ilus, graf
Artigo em Inglês | LILACS | ID: lil-468192

RESUMO

Estradiol (E2) accelerates oviductal egg transport through nongenomic pathways involving oviductal protein phosphorylation in non-mated rats, and through genomic pathways in mated rats. Here we investigated the ability of cervico-vaginal stimulation (CVS) to switch the mode of action of E2 in the absence of other male-associated components. Pro-estrous rats were subjected to CVS with a glass rod and 12 hours later were injected subcutaneously with E2 and intrabursally with the RNA synthesis inhibitor Actinomycin D or the protein phosphorylation inhibitor H-89. The number of eggs in the oviduct, assessed 24 h later, showed that Actinomycin D, but not H-89 blocked the E2-induced egg transport acceleration. This clearly indicates that CVS alone, without other mating-associated signals, is able to shift E2 signaling from nongenomic to genomic pathways. Since mating and CVS activate a neuroendocrine reflex that causes iterative prolactin (PRL) surges, the involvement of PRL pathway in this phenomenon was evaluated. Prolactin receptor mRNA and protein expression in the rat oviduct was demonstrated by RT-PCR and Western blot, but their levels were not different on day 2 of the cycle (C2) or pregnancy (P2). Activated ST AT 5a/b (phosphorylated) was detected by Western blot on P2 in the ovary, but not in the oviduct, showing that mating does not stimulate this PRL signalling pathway in the oviduct. Other rats subjected to CVS in the evening of pro-estrus were treated with bromoergocriptine to suppress PRL surges. In these rats, H-89 did not block the E2-induced acceleration of egg transport suggesting that PRL surges are not essential to shift E2 signaling pathways in the oviduct. We conclude that CVS is one of the components of mating that shifts E2 signaling in the oviduct from nongenomic to genomic pathways, and this effect is independent of PRL surges elicited by mating.


Assuntos
Animais , Feminino , Ratos , Estradiol/farmacologia , Estrogênios/farmacologia , Tubas Uterinas/efeitos dos fármacos , Transporte do Óvulo/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Dactinomicina/farmacologia , Ciclo Estral , Estradiol/administração & dosagem , Estrogênios/administração & dosagem , Tubas Uterinas/fisiologia , Isoquinolinas/farmacologia , Inibidores de Proteínas Quinases/farmacologia , Ratos Sprague-Dawley , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sulfonamidas/farmacologia
3.
Biol. Res ; 35(3/4): 333-338, 2002. ilus, graf
Artigo em Inglês | LILACS | ID: lil-339726

RESUMO

Intra-oviductal administration of RNA obtained from oviducts of estradiol-treated rats resulted in accelerated egg transport (Rios et al., 1997). It is probable that estradiol-induced messenger RNA (mRNA) entered oviductal cells and was translated into the proteins involved in accelerated egg transport. In order to test this interpretation we deposited in vivo 50 micrograms of pure beta-galactosidase (beta-gal) mRNA, 50 micrograms of pure DNA from the reporter gene beta-gal under SV40 promoter or the vehicle (control oviducts) into the oviductal lumen of rats. Twenty four hours later the beta-gal activity was assayed in oviductal tissue homogenates using o-nitrophenyl-beta-D-galactopyranoside as a substrate. The administration of beta-gal mRNA and pSVBgal plasmid increased beta-gal activity by 71% and 142%, respectively, over the control oviducts. These results indicate that naked DNA and mRNA coding for beta-gal can enter oviductal cells and be translated into an active enzyme. They are consistent with the interpretation that embryo transport acceleration caused by the injection of estradiol-induced RNA in the oviduct involves translation of the injected mRNA


Assuntos
Animais , Feminino , Ratos , beta-Galactosidase , Tubas Uterinas , Transporte do Óvulo , RNA Mensageiro , beta-Galactosidase , Tubas Uterinas , Expressão Gênica , Ratos Sprague-Dawley
5.
Biol. Res ; 27(1): 57-61, 1994. graf
Artigo em Inglês | LILACS | ID: lil-225970

RESUMO

We have previously reported that a single injection of estradiol-17 beta (E2) given on day 3 of pregnancy (P3) is far more effective for accelerating oviductal transport in the rat, than treatment given on day 1 (P1). In order to quantify this change, dose-response curves were established for six different doses of E2 (range 0.031 to 1.00 micrograms per animal) given on P1, P2 or P3. In addition, a possible mechanism was explored by comparing the plasmatic and oviductal levelsof E2 between 30 and 180 min following treatment with E2 on P1 or P3. As the interval from ovulation to treatment was increased, the transport of a larger number of embryos was accelerated and a smaller dose was required. The minimal effective dose decreased 30-fold from P1 to P3, the oviducts accumulated 20 percent to 90 percent more E2 on P3 than on P1, tissuelevels were 6- to 48-fold higher than plasma levels and the latter did not differ between P1 and P3. It is concluded that the oviduct exhibits increased sensitivity and responsiveness to E2 on P3 and this isassociated with greater accumulation of the hormone in the organ, not attributable to higher E2 plasma levels


Assuntos
Animais , Feminino , Ratos , Gravidez , Estradiol/administração & dosagem , Transporte do Óvulo/efeitos dos fármacos , Prenhez/efeitos dos fármacos , Ratos Sprague-Dawley , Fatores de Tempo , Distribuição Tecidual , Relação Dose-Resposta a Droga , Estradiol/sangue , Estradiol/farmacocinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA